# Estimating the Impact of Obesity Medications on Clinical and Economic Outcomes

> **NCT07640139** · — · ENROLLING_BY_INVITATION · sponsor: **Indiana University** · enrollment: 125000 (estimated)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Incretin-based therapies (GLP-1 and GLP-1/GIP)

## Key facts

- **NCT ID:** NCT07640139
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-01-01
- **Primary completion:** 2029-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 125000 (ESTIMATED)
- **Last updated:** 2026-06-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07640139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07640139, "Estimating the Impact of Obesity Medications on Clinical and Economic Outcomes". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07640139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*